The potential impact of COVID-19 on cancer mortality in the UK

Written by Karol Sikora (Rutherford Health plc, Hereford, UK)

Coronavirus has meant that cancer diagnostics and treatment have been put on hold. This pandemic has thrown our already stretched cancer services into disarray. Many patients have had their treatment rightly stopped because of the immunosuppressive impact, but we are seeing a wider scale rationing of cancer services. Every day I receive dozens of tweets and emails from cancer patients who have had their treatment or check-ups delayed. Good friends of mine have had their chemotherapy delayed with no good reason, or even stopped altogether. Receiving a templated email telling you not to come for further treatment is not the...

To view this content, please register now for access

It's completely free